193 related articles for article (PubMed ID: 33817229)
1. Buformin suppresses osteosarcoma via targeting AMPK signaling pathway.
Ding Y; Lv S; Li G; Cui J; Chen Y
Open Life Sci; 2020; 15(1):409-417. PubMed ID: 33817229
[TBL] [Abstract][Full Text] [Related]
2. Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
Li J; Chen L; Liu Q; Tang M; Wang Y; Yu J
Cancer Biol Ther; 2018 Jun; 19(6):507-517. PubMed ID: 29400636
[TBL] [Abstract][Full Text] [Related]
3. Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway.
Li HB; Chen JK; Su ZX; Jin QL; Deng LW; Huang G; Shen JN
Cancer Cell Int; 2021 Dec; 21(1):706. PubMed ID: 34953496
[TBL] [Abstract][Full Text] [Related]
4. Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.
Kilgore J; Jackson AL; Clark LH; Guo H; Zhang L; Jones HM; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Am J Transl Res; 2016; 8(6):2705-15. PubMed ID: 27398153
[TBL] [Abstract][Full Text] [Related]
5.
Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
[No Abstract] [Full Text] [Related]
6. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X
Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931
[TBL] [Abstract][Full Text] [Related]
7. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
[TBL] [Abstract][Full Text] [Related]
9. Ebastine exerts antitumor activity and induces autophagy by activating AMPK/ULK1 signaling in an IPMK-dependent manner in osteosarcoma.
Pan Z; Li SJ; Guo H; Li ZH; Fei X; Chang SM; Yang QC; Cheng DD
Int J Biol Sci; 2023; 19(2):537-551. PubMed ID: 36632464
[TBL] [Abstract][Full Text] [Related]
10. Propofol inhibits the malignant development of osteosarcoma U2OS cells via AMPK/FΟΧO1-mediated autophagy.
Dai L; Li S; Li X; Jiang B
Oncol Lett; 2022 Sep; 24(3):310. PubMed ID: 35949604
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27.
Hu XH; Zhao ZX; Dai J; Geng DC; Xu YZ
J Cell Biochem; 2019 Mar; 120(3):4665-4674. PubMed ID: 30582227
[TBL] [Abstract][Full Text] [Related]
12. Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway.
Gao X; Zhang C; Wang Y; Zhang P; Zhang J; Hong T
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802664
[TBL] [Abstract][Full Text] [Related]
13. 12 T high static magnetic field suppresses osteosarcoma cells proliferation by regulating intracellular ROS and iron status.
Wang S; Huyan T; Lou C; Shang P; Zhang H
Exp Cell Res; 2022 Aug; 417(2):113223. PubMed ID: 35643180
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
Zhang W; Li Q; Song C; Lao L
Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
[TBL] [Abstract][Full Text] [Related]
17. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
18. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
19. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
Li D; Yang J; Ma H; Sun C; Feng R
J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
[TBL] [Abstract][Full Text] [Related]
20. Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway.
Yong L; Ma Y; Zhu B; Liu X; Wang P; Liang C; He G; Zhao Z; Liu Z; Liu X
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1009-1020. PubMed ID: 30267330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
